Evidence map›Paper›PMID 41562606›Full record

ArticleApplied and environmental microbiology2026

Structural basis for the extended-spectrum antimicrobial activity of Garvieacin Q.

Jinsong Duan, Dan Li, Yuqing Zhao, Jiawei Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Applied and environmental microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jinsong Duan *State Key Laboratory of Membrane Biology, Beijing Frontier Research Center for Biological Structure, School of Life Sciences, Tsinghua University, Beijing, People's Republic of China.
Dan Li *State Key Laboratory of Membrane Biology, Beijing Frontier Research Center for Biological Structure, School of Life Sciences, Tsinghua University, Beijing, People's Republic of China.
Yuqing Zhao *State Key Laboratory of Membrane Biology, Beijing Frontier Research Center for Biological Structure, School of Life Sciences, Tsinghua University, Beijing, People's Republic of China.
Jiawei WangState Key Laboratory of Membrane Biology, Beijing Frontier Research Center for Biological Structure, School of Life Sciences, Tsinghua University, Beijing, People's Republic of China.ORCID 0000-0001-9893-8539

Funding

National Natural Science Foundation of China 32171190National Natural Science Foundation of China 32371254
6 · The paper itself

Abstract

Class IIa and IId bacteriocins are antimicrobial peptides with potential for combating antibiotic-resistant pathogens. However, their species-specific activity, dictated by recognition of the mannose phosphotransferase system (Man-PTS) receptor, often restricts their spectrum. Garvieacin Q/Garvicin Q (GarQ), a newly identified class IId bacteriocin, is unusual in that it targets both

Indexed as

Anti-Bacterial AgentsBacteriocinsLactococcusListeria monocytogenesAntimicrobial PeptidesPhosphoenolpyruvate Sugar Phosphotransferase SystemAnti-Bacterial AgentsAntimicrobial PeptidesBacteriocinsphosphoenolpyruvate-mannose phosphotransferasePhosphoenolpyruvate Sugar Phosphotransferase Systemantibiotic resistanceantimicrobial peptidesbacteriocinsGarQGarvieacin Qmannose phosphotransferase systemMan-PTSnon-pediocin-like/class IId bacteriocins

Identifiers

PMID41562606
PMCPMC12915331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.